Luc Friboulet discusses in depth the mechanisms of resistance to tyrosine kinase inhibitors (TKIs), provides overview of current research initiatives in the field and discuss future challenges in precision medicine posed by resistance mechanisms.
Produced by the European Society for Medical Oncology
http://www.esmo.org